Manhattan Associates Inc vs 10X Genomics Inc — how do they compare? Manhattan Associates Inc trades at $161 (market cap $9.79B), while 10X Genomics Inc trades at $45.12 (market cap $5.48B). The key difference: Manhattan Associates Inc is the larger of the two by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Manhattan Associates Inc nearer its low. Which is the better fit depends on your goals.
| MANH | TXG | |
|---|---|---|
Market Cap | $9.79B | $5.48B |
Sector | Technology | Health |
52-Week High | $227.94 | $45.80 |
52-Week Low | $120.88 | $11.34 |
Enterprise Value | $9.62B | $5.02B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $43.18, down 1.28% today, with a bullish technical signal and positive earnings momentum. The stock shows improving fundamentals with revenue growth to $642.82M in 2025 and narrowing losses, while maintaining a strong gross margin of 69.6%. Recent acquisitions and partnerships with Cleveland Clinic demonstrate strategic expansion in genomic diagnostics.
The outlook remains cautiously optimistic with analyst consensus at Buy (45%) and price target of $39.14. Key risks include continued negative profitability metrics and high valuation multiples, while catalysts include upcoming Q2 2026 earnings and platform adoption growth.
Trailing returns across standard periods
Latest headlines on both assets
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →